Ethyl pyruvate

Current Opinion in Anaesthesiology

Volumn 21, Issue 2, 2008, Pages 160-167

  Fink, Mitchell P ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Logical Therapeutics Inc   (United States)

Author keywords

Mitogen activated protein kinase; Nuclear factor b; Reactive oxygen species; Sepsis

Indexed keywords

ETHYL PYRUVIC ACID; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; NEUROPROTECTIVE AGENT; PYRUVIC ACID ETHYL ESTER;

ACUTE KIDNEY FAILURE; ACUTE PANCREATITIS; ADULT RESPIRATORY DISTRESS SYNDROME; AQUEOUS SOLUTION; BACTERIAL PERITONITIS; BLOOD CLOTTING; BURN; CELL DAMAGE; CONTINUOUS INFUSION; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEMORRHAGIC SHOCK; HUMAN; ISCHEMIA; LUNG INJURY; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; REPERFUSION INJURY; REVIEW; SEPSIS; SEPTIC SHOCK; STROKE; SURVIVAL RATE; PANCREATITIS;

ANTI-INFLAMMATORY AGENTS; HUMANS; NEUROPROTECTIVE AGENTS; PANCREATITIS; PYRUVATES; REPERFUSION INJURY; SEPSIS; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC;

EID: 43249094826     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3282f63c2e     Document Type: Review

References (88)

1. O'Donnell-Tormey J, Nathan CF, Lanks K, et al. Secretion of pyruvate: an antioxidant defense of mammalian cells. J Exp Med 1987; 165:500-514.
2. Brand K. Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr 1997; 29:355-364.
3. Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 1997; 11:388-395.
4. Holleman MAF. Report on the action of hydrogen peroxide on ketones and diketones 1.2. Recl Trav Chim Pays-bas Belg 1904; 23:169-171.
5. Dobsak P, Courdertot-Masuyer C, Zeller M, et al. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol 1999; 34:651-659.
6. Salahudeen AK, Clark EC, Nath KA. Hydrogen peroxide-induced renal injury: a protective role for pyruvate in vitro and in vivo. J Clin Invest 1991; 88:1886-1893.
7. Bunger R, Mallet RT, Hartman DA. Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart: nearcomplete prevention of reperfusion contractile failure. Eur J Biochem 1989; 180:221-233.
8. Cicalese L, Lee K, Schraut W, et al. Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. Am J Surg 1999; 171:97-100.
9. Sileri P, Schena S, Morini S, et al. Pyruvate inhibits hepatic ischemiareperfusion injury in rats. Transplantation 2001; 72:27-30.
10. Gupta SK, Mohanty I, Trivedi D, et al. Pyruvate inhibits galactosemic changes in cultured cat lens epithelial cells. Ophthalmic Res 2002; 34:23-28.
11. Kalakonda S, Hegde KR, Varma SD. Ophthalmoscopic and morphogenetic changes in rat lens induced by galactose: attenuation by pyruvate. Diabetes Obes Metab 2004; 6:216-222.
12. Zhao W, Devamanoharan PS, Henein M, et al. Diabetes-induced biochemical changes in rat lens: attenuation of cataractogenesis by pyruvate. Diabetes Obes Metab 2000; 2:165-174.
13. Lee JY, Kim YH, Koh JY. Protection by pyruvate against transient forebrain ischemia in rats. J Neurosci 2001; 21:1-6.
14. Kim JB, Yu YM, Kim SW, Lee JK. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 2005; 1060:188-192.
15. Slovin PN, Huang CJ, Cade JR, et al. Sodium pyruvate is better than sodium chloride as a resuscitation solution in a rodent model of profound hemorrhagic shock. Resuscitation 2001; 50:109-115.
16. Mongan PD, Capacchione J, West S, et al. Pyruvate improves redox status and decreases indicators of hepatic apoptosis during hemorrhagic shock in swine. Am J Physiol Heart Circ Physiol 2002; 283:H1634-H1644.
17. Mongan PD, Capacchione J, Fontana JL, et al. Pyruvate improves cerebral metabolism during hemorrhagic shock. Am J Physiol 2001; 281:H854-H864.
18. Mongan PD, Fontana JL, Chen R, Bunger R. Intravenous pyruvate prolongs survival during hemorrhagic shock in swine. Am J Physiol 1999; 277:H2253-H2263.
19. Lee JY, Lee JY, Lee SE, et al. Protection by pyruvate of rat retinal cells against zinc toxicity in vitro, and pressure-induced ischemia in vivo. Invest Ophthalmol Vis Sci 2004; 45:1523-1530.
20. Varma SD, Devamanoharan PS, Rutzen AR, et al. Attenuation of galactoseinduced cataract by pyruvate. Free Rad Res 1999; 30:253-263.
21. Zhao W, Devamanoharan PS, Varma SD. Fructose induced deactivation of antioxidant enzymes: preventive effect of pyruvate. Free Rad Res 2000; 33:23-30.
22. Varma SD, Devamanoharan PS, Ali AH. Prevention of intracellular oxidative stress to lens by pyruvate and its ester. Free Rad Res 1998; 28:131-135.
23. Montgomery CM, Webb JL. Metabolic studies on heart mitochondria. II: The inhibitory action of parapyruvate on the tricarboxylic acid cycle. J Biol Chem 1956; 221:359-368.
24. 14, purity and stability. Anal Biochem 1964; 8:1 71-178.
25. Montgomery CM, Fairhurst AS, Webb JL. Metabolic studies on heart mitochondria. III: The action of parapyruvate on a-ketoglutaric oxidase. J Biol Chem 1956; 221:369-376.
26. Margolis SA, Coxon B. Identification and quantitation of the impurities in sodium pyruvate. Anal Biochem 1986; 58:2504-2510.
27. Sims CA, Wattanasirichaigoon S, Menconi MJ, et al. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med 2001; 29:1513-1518.
28. Tawadrous ZS, Delude RL, Fink MP. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 2002; 17:473-477.
29. Yang R, Gallo DJ, Baust JJ, et al. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 2002; 283:G212-G222.
30. Gupta SK, Rastogi S, Prakash J, et al. Anti-inflammatory activity of sodium pyruvate: a physiological antioxidant [abstract]. Indian J Physiol Pharmacol 2000; 44:101-104.
31. Mollen KP, McCloskeyCA, TanakaH, et al. Hypoxia activates c-Jun. N-terminal kinase via Rac1-dependent reactive oxygen species production in hepatocytes. Shock 2007; 28:270-277.
32. This paper provides further evidence that ethyl pyruvate exerts anti-inflammatory effects.
33. Mulier KE, Beilman GJ, Conroy MJ, et al. Ringer's ethyl pyruvate in hemorrhagic shock and resuscitation does not improve early hemodynamics or tissue energetics. Shock 2005; 23:248-252.
34. Venkataraman R, Kellum JA, Song M, Fink MP. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 2002; 18:507-512.
35. Ulloa L, Ochani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 2002; 99:12351-12356.
36. Fink MP, Heard SO. Research review: laboratory models of sepsis and septic shock. J Surg Res 1990; 49:186-196.
37. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251.
38. Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous HMGB1. Proc Natl Acad Sci USA 2004; 101:296-301.
39. Hauser B, Kick J, Asfar P, et al. Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia. Crit Care Med 2005; 33:2034-2042.
40. Su F, Wang Z, Cai Y, et al. Beneficial effects of ethyl pyruvate in septic shock from peritonitis. Arch Surg 2007; 142:166-171.
41. Delayed treatment with ethyl pyruvate prolongs survival and ameliorates organ dysfunction in a clinically relevant large animal model of adequately resuscitated severe sepsis.
42. van Zoelen MA, de Vos AF, Larosa GJ, et al. Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide-and lipoteichoic acid-induced lung inflammation in vivo. Shock 2007; 28:570-575.
43. Even when delivered directly into the lungs, ethyl pyruvate exerts anti-inflammatory effects.
44. Miyaji T, Hu X, Yuen PST, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 2003; 64:1620-1631.
45. Dear JW, Kobayashi H, Jo SK, et al. Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int 2005; 67:2159-2167.
46. Venkataraman R, Keluum JA, Song M, Fink MP. Treatment with Ringer's ethyl pyruvate solution (REPS) improves survival time in rat endotoxemic shock model. Crit Care Med 2001; 29 (Suppl): A86.
47. Andersson A, Fenhammar J, Frithiof R, et al. Haemodynamic and metabolic effects of resuscitation with Ringer's ethyl pyruvate in the acute phase of porcine endotoxaemic shock. Acta Anaesthesiol Scand 2006; 50:11 98-1206.
48. KlenzakJ, Himmelfarb J. Sepsis and the kidney. Crit Care Clin 2005; 21:211-222.
49. Wang O, Yao YM, Wang YB, et al. Effect of ethyl pyruvate on renal high mobility group box-1 protein expression and acute kidney injury in rats with delayed resuscitation after thermal injury. Zhonghua Wai Ke Za Zhi 2007; 45:1210-1213.
50. Yang R, UchiyamaT, AlberSM, et al. Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis. Crit Care Med 2004; 32:1453-1459.
51. Cheng BO, Liu CT, Li WJ, et al. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas 2007; 35:256-261.
52. This study confirms that delayed treatment with ethyl pyruvate can ameliorate organ dysfunction in a rodent model of acute pancreatitis, and suggests that inhibition of HMGB1 secretion may be an underlying mechanism for this pharmacological effect.
53. Dong YQ, Yao YM, Wei P, et al. Effects of ethyl pyruvate on cell-mediated immune function in rats with delayed resuscitation after burn injury. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005; 17:12-15.
54. Dong N, Yao YM, Dong YO, et al. Effects of ethyl pyruvate on splenocyte proliferation and apoptosis in burn rats with delayed resuscitation. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005; 17:393-396.
55. Wang WJ, Yao YM, Xian LM, et al. Effect of treatment with ethyl pyruvate on multiple organ dysfunction and mortality following delayed resuscitation after burn injury in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006; 1 8: 132-135.
56. Karabeyoglu M, Kocer B, Ozel U, et al. The protective effect of ethyl pyruvate on lung injury after burn in rats. Saudi Med J 2007; 28:489-492.
57. Karabeyoglu M, Unal BU, Bozkurt BE, et al. The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury. J Surg Res 2008; 144:56-63.
58. Epperly M, Jin S, Nie S, et al. Ethyl pyruvate, a potentially effective mitigator of damage after total-body irradiation. Radiat Res 2007; 168:552-559.
59. Delayed treatment with ethyl pyruvate can rescue mice from the lethal effects of whole-body ionizing radiation.
60. van Zoelen MA, Bakhtiari K, Dessing MC, et al. Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells. Thromb Haemost 2006; 96:789-793.
61. Ethyl pyruvate inhibits tissue factor expression by immunostimulated monocytes.
62. Uchiyama T, Delude RL, Fink MP. Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion. Intensive Care Med 2003; 29:2050-2058.
63. Woo YJ, Taylor MD, Cohen JE, et al. Ethyl pyruvate preserves cardiac function and attenuates infarct size following prolonged myocardial ischemia. J Thorac Cardiovasc Surg 2004; 127:1262-1269.
64. Tsung A, Kaizu T, Nakao A, et al. Ethyl pyruvate ameliorates liver ischemiareperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation 2005; 27:196-204.
65. Sappington PL, Han X, Yang R, et al. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated Caco-2 enterocytic monolayers. J Pharmacol Exp Ther 2003; 304:464-476.
66. Chavez A, Menconi MJ, Hodin RA, Fink MP. Cytokine-induced epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999; 27:2246-2251.
67. Gonzalez-Falcon A, Candelario-Jalil E, Garcia-Cabrera M, Leon OS. Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats. Brain Res 2003; 990: 1-7.
68. Yu YM, Kim JB, Lee KW, et al. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 2005; 36:2238-2243.
69. Zeng J, Liu J, Yang GY, et al. Exogenous ethyl pyruvate versus pyruvate during metabolic recovery after oxidative stress in neonatal rat cerebrocortical slices. Anesthesiology 2007; 107:630-640.
70. This series of elegant in-vitro experiments supports the view that ethyl pyruvate and pyruvate are pharmacologically distinct entities.
71. Siggins JE, Harding HR, Potts GO. Hypoglycemic esters of 2-chloroethanol. J Med Chem 1969; 12:941-943.
72. Mertz RJ, Worley JFI, Spencer B, et al. Activation of stimulus-secretion coupling in pancreatic p-cells by specific products of glucose metabolism. J Biol Chem 1996; 271:4838-4845.
73. Zawalich WS, Zawalich KC. Influence of pyruvic acid methyl ester on rat pancreatic islets: effects on insulin secretion, phosphoinositide hydrolysis, and sensitization of the beta cell. J Biol Chem 1997; 272:3527-3531.
74. Malaisse WJ, Jijakli H, Ulusoy S, et al. Insulinotropic action of methyl pyruvate: secretory, cationic, and biosynthetic aspects. Arch Biochem Biophys 1996; 335:229-244.
75. Rocheleau JV, Head WS, Piston DW. Quantitative NAD (P) H/flavoprotein autofluorescence imaging reveals metabolic mechanisms of pancreatic islet pyruvate response. J Biol Chem 2004; 279:31780-31787.
76. Wang LZ, Sun WC, Zhu XZ. Ethyl pyruvate protects PC12 cells from dopamine-induced apoptosis. Eur J Pharmacol 2005; 508:57-68.
77. Cho IH, Kim SW, Kim JB, et al. Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Neuroscience Res 2006; 84:1505-1511.
78. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappaB by a posttranslational mechanism. Cell 1986; 47:921-928.
79. Yang R, Han X, Delude RL, Fink MP. Ethyl pyruvate ameliorates acute alcoholinduced liver injury and inflammation in mice. J Lab Clin Med 2003; 142:322-331.
80. Sappington PL, Han X, Yang R, et al. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated Caco-2 enterocytic monolayers. J Pharmacol Exp Ther 2003; 304:464-476.
81. Song M, Kellum JA, Kaldas H, Fink MP. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured LPS-stimulated RAW 264.7 cells. J Pharmacol Exp Ther 2004; 308: 307-316.
82. Haddad JJ. Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factorkappaB. Crit Care 2002; 6:481-490.
83. Sappington PL, Fink ME, Yang R, et al. Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock 2003; 20:521-528.
84. Sappington PL, Cruz RJ Jr, Harada T, et al. The ethyl pyruvate analogues, diethyl oxaloproprionate, 2-acetamidoacrylate, and methyl-2-acetamidoacrylate, exhibit anti-inflammatory properties in vivo and/or in vitro. Biochem Pharmacol 2005; 70:1579-1592.
85. Lyss G, Knorre A, Schmidt TJ, et al. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 1998; 273:33508-33516.
86. Schmidt TJ, Lyss G, Pahl HL, Merfort I. Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions. Bioorg Med Chem 1999; 7:2849-2855.
87. Garcia-Pineres AJ, Castro V, Mora G, et al. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 2001; 276:39713-39720.
88. Han Y, Englert JA, Yang R, et al. Ethyl pyruvate inhibits NF-κB-dependent signaling by directly targeting p65. J Pharmacol Exp Ther 2005; 312:1097-1115.